- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.10 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 6 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x HUW: HUPRINE W(Non-covalent)
HUW.2: 10 residues within 4Å:- Chain A: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:W.86, A:W.86, A:W.439, A:Y.449
- Hydrogen bonds: A:G.121, A:G.122, A:S.203, A:S.203
- Water bridges: A:T.83, A:Y.341
- pi-Stacking: A:W.86, A:W.86, A:Y.337
HUW.15: 10 residues within 4Å:- Chain C: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:W.86, C:W.86, C:W.439, C:Y.449
- Hydrogen bonds: C:G.121, C:G.122, C:S.203, C:S.203
- Water bridges: C:D.74, C:Y.341
- pi-Stacking: C:W.86, C:W.86, C:Y.337
HUW.28: 10 residues within 4Å:- Chain E: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:W.86, E:W.86, E:W.439, E:Y.449
- Hydrogen bonds: E:G.121, E:G.122, E:S.203, E:S.203
- Water bridges: E:D.74, E:Y.341
- pi-Stacking: E:W.86, E:W.86, E:Y.337
HUW.41: 10 residues within 4Å:- Chain G: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain G- Hydrophobic interactions: G:W.86, G:W.86, G:W.439, G:Y.449
- Hydrogen bonds: G:G.121, G:G.122, G:S.203, G:S.203
- Water bridges: G:T.83, G:Y.341
- pi-Stacking: G:W.86, G:W.86, G:Y.337
HUW.54: 10 residues within 4Å:- Chain I: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain I- Hydrophobic interactions: I:W.86, I:W.86, I:W.439, I:Y.449
- Hydrogen bonds: I:G.121, I:G.122, I:S.203, I:S.203
- Water bridges: I:T.83, I:Y.341
- pi-Stacking: I:W.86, I:W.86, I:Y.337
HUW.67: 10 residues within 4Å:- Chain K: W.86, G.121, G.122, E.202, S.203, Y.337, F.338, W.439, H.447, Y.449
13 PLIP interactions:13 interactions with chain K- Hydrophobic interactions: K:W.86, K:W.86, K:W.439, K:Y.449
- Hydrogen bonds: K:G.121, K:G.122, K:S.203, K:S.203
- Water bridges: K:D.74, K:Y.341
- pi-Stacking: K:W.86, K:W.86, K:Y.337
- 60 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 2 residues within 4Å:- Chain A: M.241, G.242
Ligand excluded by PLIPCL.4: 1 residues within 4Å:- Chain A: R.417
Ligand excluded by PLIPCL.5: 1 residues within 4Å:- Chain A: R.356
Ligand excluded by PLIPCL.6: 1 residues within 4Å:- Chain A: R.224
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain A: P.108, R.143
Ligand excluded by PLIPCL.8: 1 residues within 4Å:- Chain A: R.136
Ligand excluded by PLIPCL.9: 2 residues within 4Å:- Chain A: R.219, D.320
Ligand excluded by PLIPCL.10: 2 residues within 4Å:- Chain A: R.16, G.58
Ligand excluded by PLIPCL.11: 4 residues within 4Å:- Chain A: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.12: 1 residues within 4Å:- Chain A: E.376
Ligand excluded by PLIPCL.16: 2 residues within 4Å:- Chain C: M.241, G.242
Ligand excluded by PLIPCL.17: 1 residues within 4Å:- Chain C: R.417
Ligand excluded by PLIPCL.18: 1 residues within 4Å:- Chain C: R.356
Ligand excluded by PLIPCL.19: 1 residues within 4Å:- Chain C: R.224
Ligand excluded by PLIPCL.20: 2 residues within 4Å:- Chain C: P.108, R.143
Ligand excluded by PLIPCL.21: 1 residues within 4Å:- Chain C: R.136
Ligand excluded by PLIPCL.22: 2 residues within 4Å:- Chain C: R.219, D.320
Ligand excluded by PLIPCL.23: 2 residues within 4Å:- Chain C: R.16, G.58
Ligand excluded by PLIPCL.24: 4 residues within 4Å:- Chain C: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.25: 1 residues within 4Å:- Chain C: E.376
Ligand excluded by PLIPCL.29: 2 residues within 4Å:- Chain E: M.241, G.242
Ligand excluded by PLIPCL.30: 1 residues within 4Å:- Chain E: R.417
Ligand excluded by PLIPCL.31: 1 residues within 4Å:- Chain E: R.356
Ligand excluded by PLIPCL.32: 1 residues within 4Å:- Chain E: R.224
Ligand excluded by PLIPCL.33: 2 residues within 4Å:- Chain E: P.108, R.143
Ligand excluded by PLIPCL.34: 1 residues within 4Å:- Chain E: R.136
Ligand excluded by PLIPCL.35: 2 residues within 4Å:- Chain E: R.219, D.320
Ligand excluded by PLIPCL.36: 2 residues within 4Å:- Chain E: R.16, G.58
Ligand excluded by PLIPCL.37: 4 residues within 4Å:- Chain E: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.38: 1 residues within 4Å:- Chain E: E.376
Ligand excluded by PLIPCL.42: 2 residues within 4Å:- Chain G: M.241, G.242
Ligand excluded by PLIPCL.43: 1 residues within 4Å:- Chain G: R.417
Ligand excluded by PLIPCL.44: 1 residues within 4Å:- Chain G: R.356
Ligand excluded by PLIPCL.45: 1 residues within 4Å:- Chain G: R.224
Ligand excluded by PLIPCL.46: 2 residues within 4Å:- Chain G: P.108, R.143
Ligand excluded by PLIPCL.47: 1 residues within 4Å:- Chain G: R.136
Ligand excluded by PLIPCL.48: 2 residues within 4Å:- Chain G: R.219, D.320
Ligand excluded by PLIPCL.49: 2 residues within 4Å:- Chain G: R.16, G.58
Ligand excluded by PLIPCL.50: 4 residues within 4Å:- Chain G: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.51: 1 residues within 4Å:- Chain G: E.376
Ligand excluded by PLIPCL.55: 2 residues within 4Å:- Chain I: M.241, G.242
Ligand excluded by PLIPCL.56: 1 residues within 4Å:- Chain I: R.417
Ligand excluded by PLIPCL.57: 1 residues within 4Å:- Chain I: R.356
Ligand excluded by PLIPCL.58: 1 residues within 4Å:- Chain I: R.224
Ligand excluded by PLIPCL.59: 2 residues within 4Å:- Chain I: P.108, R.143
Ligand excluded by PLIPCL.60: 1 residues within 4Å:- Chain I: R.136
Ligand excluded by PLIPCL.61: 2 residues within 4Å:- Chain I: R.219, D.320
Ligand excluded by PLIPCL.62: 2 residues within 4Å:- Chain I: R.16, G.58
Ligand excluded by PLIPCL.63: 4 residues within 4Å:- Chain I: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.64: 1 residues within 4Å:- Chain I: E.376
Ligand excluded by PLIPCL.68: 2 residues within 4Å:- Chain K: M.241, G.242
Ligand excluded by PLIPCL.69: 1 residues within 4Å:- Chain K: R.417
Ligand excluded by PLIPCL.70: 1 residues within 4Å:- Chain K: R.356
Ligand excluded by PLIPCL.71: 1 residues within 4Å:- Chain K: R.224
Ligand excluded by PLIPCL.72: 2 residues within 4Å:- Chain K: P.108, R.143
Ligand excluded by PLIPCL.73: 1 residues within 4Å:- Chain K: R.136
Ligand excluded by PLIPCL.74: 2 residues within 4Å:- Chain K: R.219, D.320
Ligand excluded by PLIPCL.75: 2 residues within 4Å:- Chain K: R.16, G.58
Ligand excluded by PLIPCL.76: 4 residues within 4Å:- Chain K: R.525, A.526, Q.527, A.528
Ligand excluded by PLIPCL.77: 1 residues within 4Å:- Chain K: E.376
Ligand excluded by PLIP- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 4 residues within 4Å:- Chain A: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.504, A:A.505, A:G.506, A:A.507
SO4.26: 4 residues within 4Å:- Chain C: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:T.504, C:A.505, C:G.506, C:A.507
SO4.39: 4 residues within 4Å:- Chain E: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:T.504, E:A.505, E:G.506, E:A.507
SO4.52: 4 residues within 4Å:- Chain G: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:T.504, G:A.505, G:G.506, G:A.507
SO4.65: 4 residues within 4Å:- Chain I: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain I- Hydrogen bonds: I:T.504, I:A.505, I:G.506, I:A.507
SO4.78: 4 residues within 4Å:- Chain K: T.504, A.505, G.506, A.507
4 PLIP interactions:4 interactions with chain K- Hydrogen bonds: K:T.504, K:A.505, K:G.506, K:A.507
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase. Biochem. J. (2013)
- Release Date
- 2013-05-29
- Peptides
- ACETYLCHOLINESTERASE: ACEGIK
FASCICULIN-2: BDFHJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AB
BD
BF
BH
BJ
BL
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.10 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 6 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x HUW: HUPRINE W(Non-covalent)
- 60 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase. Biochem. J. (2013)
- Release Date
- 2013-05-29
- Peptides
- ACETYLCHOLINESTERASE: ACEGIK
FASCICULIN-2: BDFHJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AB
BD
BF
BH
BJ
BL
B